- Eating disorders are not about food. They are about self-image, identity rigidity, control, and trauma. Standard care helps roughly half of patients reach full remission.
- Anorexia nervosa has the highest mortality rate of any psychiatric illness (~10% in long-term cohorts). Treatment urgency is real.
- JHU and Imperial pilot data on psilocybin for anorexia (Peck, Spaeth, et al. 2023) shows feasibility, with significant reduction in eating disorder cognitions in some responders. Sample sizes are small.
- Mechanism logic: 5-HT2A activation reduces default-mode network rigidity, the same rigidity that locks in self-image distortion. Plus a 30-day plasticity window for therapy to land.
- Severe medical instability (low BMI, electrolyte imbalance, refeeding risk) is a hard contraindication. Stabilize medically first.
Eating disorders, in plain terms
Eating disorders are mental illnesses with severe disturbances in eating behavior, body image, and self-evaluation. The DSM categories most often discussed:
- Anorexia nervosa: restriction of intake, intense fear of weight gain, distorted body image. Highest mortality of any psychiatric disorder.
- Bulimia nervosa: binge episodes followed by compensatory behaviors (vomiting, exercise, laxatives).
- Binge eating disorder (BED): recurrent binge episodes without compensatory behaviors. Most common eating disorder.
- ARFID, OSFED: atypical or other specified presentations, increasingly recognized.
Standard care, and where it falls short
Anorexia: medical stabilization first, then family-based therapy (FBT, gold standard for adolescents) or CBT-E for adults. Inpatient refeeding for severe cases.
Bulimia and BED: CBT-E is first-line, SSRIs (fluoxetine FDA approved for bulimia), DBT for emotion regulation.
The gap: anorexia has roughly 50% remission at 5-year follow-up. Many patients chronify. Identity and self-image distortions are the hardest part to shift, especially in long-duration anorexia.
Why psilocybin is being studied for eating disorders
Three reasons drove the research interest:
- The condition is identity-rigid. Patients describe the eating disorder as part of who they are. Standard cognitive interventions struggle here. Psilocybin’s documented “ego dissolution” or perspective-shift effects may temporarily loosen that rigidity.
- High trauma comorbidity. Trauma history is common in eating disorders. Psilocybin’s emerging trauma-trauma effect is mechanistically relevant.
- 5-HT2A and self-perception. The same receptor system that drives the trip overlaps with circuits governing interoception and body schema, both disrupted in eating disorders.
Mechanism on body image and self-perception
- Default-mode network softening. The DMN is heavily involved in self-referential thought, including body-image rumination. Psilocybin reduces DMN integrity acutely. Patients may briefly experience body and identity from outside the disorder’s frame.
- Neuroplasticity window. ~30 days post-session of elevated BDNF and dendritic spine density (Olson lab) supports therapy-driven re-encoding.
- Mystical-type experience and predictors of response. Across psychedelic trials, mystical-type experience scores correlate with outcome. Eating disorder responders in the small trials so far had high mystical scores.
Research summary
| Study | Year | Design | Finding |
|---|---|---|---|
| Peck, Spaeth et al. JHU/Imperial AN | 2023 | Open-label feasibility, n=10 anorexia | Feasible and well-tolerated; reduction in ED cognitions in some |
| Davis et al., MDD trial (relevance) | 2020 | RCT, n=27 | 71% response in MDD; relevant for ED comorbid depression |
| JHU anorexia Phase 2 (in progress) | 2024-2026 | Larger trial | Pending |
| BED MDMA-assisted therapy pilot (MAPS) | 2024 | Pilot, n=18 | Reduction in binge frequency, well-tolerated |
| Bulimia or BED psilocybin RCT | — | — | None published to date |
Trial protocols
The JHU anorexia trial used 1 to 2 doses of 25 mg synthetic psilocybin with at least 2 preparation sessions and 3-6 integration sessions. Eating-disorder-aware therapists, with medical monitoring (vitals, weight, electrolytes) before and after each session.
This is not a self-administer protocol. The medical fragility of restricting populations and the identity-shift potential of full-dose sessions both require trained support.
Do not pursue this if you have:
BMI below 15 or medical instability requiring refeeding · Electrolyte imbalance, recent fainting, or cardiac arrhythmia · Active purging multiple times per day · Bipolar I or family history · Schizophrenia spectrum personal/family · Currently taking lithium, MAOIs · Pregnancy · Severe cardiovascular disease · Active suicidality requiring inpatient stabilization.
Risks specific to eating disorder populations
- Medical fragility. Underweight patients have unstable cardiovascular and electrolyte states. Acute psilocybin-induced blood pressure shifts can be more dangerous here than in healthy adults.
- Refeeding syndrome. Re-introduction of nutrition in severely restricting patients is itself medically dangerous. The dose is not the place to manage it.
- Body-image amplification. The DMN softening that helps some patients amplifies dysphoria in others. Outcomes are mixed even within trial populations.
- Autoimmune comorbidity. Common in long-duration eating disorders. SSRIs often co-prescribed. Multiple interacting medications complicate planning.
- Trauma activation. High trauma history; the dose can surface unprocessed material that needs trained support to navigate.
Who should not pursue this
- Anyone medically unstable. Stabilize first under specialist eating-disorder care.
- Anyone considering this instead of evidence-based treatment (FBT, CBT-E, refeeding when needed).
- Anyone without an eating-disorder-specialist therapist for integration.
- Anyone unable to commit to nutritional rehabilitation alongside.
Integration practices that matter for ED
- Specialist therapyCBT-E, FBT, or DBT with an eating-disorder-trained clinician. Psilocybin is the catalyst; specialist work is the structure.
- Nutritional rehabilitationRegistered dietitian familiar with eating disorders. Refeeding protocols when applicable. Non-negotiable for restrictive presentations.
- Body-based practicesSoma yoga, somatic experiencing, mindful movement. Reconnection with body sensation, not body shape.
- Identity workThe post-session window is when “who am I without this” can be re-encoded. Therapy focused here, not just on eating behavior.
- Social/family supportFBT or family work; eating disorders often live in family system patterns.
- TrackingVitals, weight, electrolytes (with care to avoid weight as the primary target for non-restrictive presentations). ED cognition scales (EDE-Q).
When to seek professional help
If you have an eating disorder and are not in specialist care, that is the priority. NEDA helpline: nationaleatingdisorders.org. For crisis: 988 (US), findahelpline.com. Eating disorders carry real mortality. Standard treatment is the floor, not optional.
